There are currently 7 active clinical trials seeking participants for Hip Fractures research studies. The states with the highest number of trials for Hip Fractures participants are Ontario, New York, Pennsylvania and Massachusetts.
Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion
NCT03063892
Recruiting
Tranexamic Acid (TXA) is an antifibrolytic medication used in total hip and knee arthroplasty to reduce the need for intraoperative and postoperative blood transfusions. Limited research is available on its use in hip fracture patients. We hypothesize that the use of TXA preoperatively, perioperatively, and postoperatively will decrease blood loss and need for blood transfusion postoperatively.
Gender:
ALL
Ages:
60 years and above
Trial Updated:
09/17/2024
Locations: ProMedica Toledo Hospital, Toledo, Ohio
Conditions: Hip Fractures
Register for Updates
MDR - PMCF Study for Taperloc Complete Stems
NCT04028687
Recruiting
The objective of this consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Taperloc Complete stems when used for primary or revision total hip arthroplasty (implants) at 1,3,5,7 and 10-year follow-up\*. Since Taperloc Complete was introduced to the EU in 2010, all available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/10/2025
Locations: Orthopaedic Institute of Henderson, Henderson, Nevada +2 locations
Conditions: Hip Arthritis, Hip Disease, Hip Fractures, Hip Injuries, Hip Pain Chronic
Register for Updates
Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
NCT06278987
Recruiting
The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
11/14/2024
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: Hip Fractures
Register for Updates
HIP Fracture Accelerated Surgical TreaTment and Care TracK 2 Trial
NCT04743765
Recruiting
The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assess... Read More
Gender:
ALL
Ages:
45 years and above
Trial Updated:
11/04/2024
Locations: The Regents of the University of California, Davis, California +54 locations
Conditions: Hip Fractures, Myocardial Injury
Register for Updates
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
NCT06438640
Recruiting
The objective of this study is to assess the implementation process for and the effectiveness of a quality improvement (QI) strategy to increase shared decision-making around anesthesia options for hip fracture surgery at 6 US hospitals. The QI strategy is to be facilitated by a clinician-administered 1-page bedside conversation aid designed to improve the quality of physician-patient communication, paired with brief clinician training. The evaluation will occur via a stepped wedge, cluster rand... Read More
Gender:
ALL
Ages:
50 years and above
Trial Updated:
10/01/2024
Locations: University of Florida Gainesville, Gainesville, Florida +5 locations
Conditions: Hip Fractures, Femoral Neck Fractures, Intertrochanteric Fractures, Subtrochanteric Fractures
Register for Updates
Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®
NCT04113044
Recruiting
Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups). Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/19/2024
Locations: Cedars-Sinai Department of Orthopaedics, Los Angeles, California +12 locations
Conditions: Hip Fractures, Tibial Fractures, Ankle Fractures, Humeral Fracture, Proximal, Distal Radius Fracture
Register for Updates
Blood Loss After Early TXA in Hip Fractures.
NCT04488367
Recruiting
Our present study aims to initiate TXA administration immediately upon diagnosis of hip fracture in the Emergency Department. This will be a single blind randomized controlled trial comparing early administration of TXA in the ED in addition to perioperative dosing versus the standard perioperative administration only. The study population will include patients who have sustained a femoral neck, intertrochanteric, or subtrochanteric femur fracture and are undergoing surgical internal fixation or... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
07/18/2022
Locations: Community Memorial Hospital, Ventura, California
Conditions: Hip Fractures
Register for Updates